181 related articles for article (PubMed ID: 28627585)
21. Establishment and characterization of MTDH knockdown by artificial MicroRNA interference - functions as a potential tumor suppressor in breast cancer.
Wang S; Shu JZ; Cai Y; Bao Z; Liang QM
Asian Pac J Cancer Prev; 2012; 13(6):2813-8. PubMed ID: 22938464
[TBL] [Abstract][Full Text] [Related]
22. MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells.
Cao D; Zhu H; Zhao Q; Huang J; Zhou C; He J; Liang Y
Biol Res; 2020 Sep; 53(1):43. PubMed ID: 32993809
[TBL] [Abstract][Full Text] [Related]
23. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance mediated by AEG-1/MTDH/LYRIC.
Meng X; Thiel KW; Leslie KK
Adv Cancer Res; 2013; 120():135-57. PubMed ID: 23889990
[TBL] [Abstract][Full Text] [Related]
25. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
26. MTDH mediates estrogen-independent growth and tamoxifen resistance by down-regulating PTEN in MCF-7 breast cancer cells.
Xu C; Kong X; Wang H; Zhang N; Kong X; Ding X; Li X; Yang Q
Cell Physiol Biochem; 2014; 33(5):1557-67. PubMed ID: 24854844
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
28. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
[TBL] [Abstract][Full Text] [Related]
29. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.
Chambliss KL; Wu Q; Oltmann S; Konaniah ES; Umetani M; Korach KS; Thomas GD; Mineo C; Yuhanna IS; Kim SH; Madak-Erdogan Z; Maggi A; Dineen SP; Roland CL; Hui DY; Brekken RA; Katzenellenbogen JA; Katzenellenbogen BS; Shaul PW
J Clin Invest; 2010 Jul; 120(7):2319-30. PubMed ID: 20577047
[TBL] [Abstract][Full Text] [Related]
30. AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression.
Lee SG; Kang DC; DeSalle R; Sarkar D; Fisher PB
Adv Cancer Res; 2013; 120():1-38. PubMed ID: 23889986
[TBL] [Abstract][Full Text] [Related]
31. The role of MTDH/AEG-1 in the progression of cancer.
Shi X; Wang X
Int J Clin Exp Med; 2015; 8(4):4795-807. PubMed ID: 26131054
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of distinct oestrogen responses in endometrial and breast cancer.
Baxter E; Windloch K; Kelly G; Lee JS; Gannon F; Brennan DJ
Endocr Relat Cancer; 2019 Jan; 26(1):31-46. PubMed ID: 30121621
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of metadherin inhibits angiogenesis in breast cancer.
Liu Y; Kong X; Li X; Li B; Yang Q
Int J Oncol; 2015; 46(6):2459-66. PubMed ID: 25902416
[TBL] [Abstract][Full Text] [Related]
34. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
[TBL] [Abstract][Full Text] [Related]
35. Progress of cancer research on astrocyte elevated gene-1/Metadherin (Review).
Huang Y; Li LP
Oncol Lett; 2014 Aug; 8(2):493-501. PubMed ID: 25009642
[TBL] [Abstract][Full Text] [Related]
36. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
37. Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin.
Song Z; Wang Y; Li C; Zhang D; Wang X
PLoS One; 2015; 10(5):e0127599. PubMed ID: 25993398
[TBL] [Abstract][Full Text] [Related]
38. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
Bhat-Nakshatri P; Wang G; Appaiah H; Luktuke N; Carroll JS; Geistlinger TR; Brown M; Badve S; Liu Y; Nakshatri H
Mol Cell Biol; 2008 Dec; 28(24):7487-503. PubMed ID: 18838536
[TBL] [Abstract][Full Text] [Related]
39. Effect of modification of MTDH gene expression on colorectal cancer aggressiveness.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; Abo-Saif MA
Gene; 2019 May; 698():92-99. PubMed ID: 30836117
[TBL] [Abstract][Full Text] [Related]
40. Expression of metadherin/AEG-1 gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials.
Zhou Z; Deng H; Yan W; Huang H; Deng Y; Li Y; Tian D
J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):353-357. PubMed ID: 22684557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
